Sale!

PC Gene Leigh Syndrome Due to Pyruvate Carboxylase Deficiency Genetic Test

Original price was: $700.Current price is: $500.

-29%

The PC Gene Leigh Syndrome NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the PC gene responsible for pyruvate carboxylase deficiency, a rare metabolic disorder causing Leigh syndrome. This advanced next-generation sequencing test provides precise genetic analysis to confirm diagnosis, guide treatment strategies, and enable family planning decisions. Early detection through this test can significantly improve patient outcomes by allowing timely intervention and specialized care management. The test is particularly crucial for infants and children showing neurological symptoms, developmental delays, or metabolic abnormalities. With results available in 3-4 weeks and a discounted price of $500 USD, this test offers accessible genetic testing for families across the United States.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

PC Gene Leigh Syndrome Due to Pyruvate Carboxylase Deficiency NGS Genetic DNA Test

Comprehensive Genetic Testing for Rare Neurological Disorders

The PC Gene Leigh Syndrome NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying pyruvate carboxylase deficiency, a rare autosomal recessive metabolic disorder that leads to Leigh syndrome. This neurological condition primarily affects the central nervous system and can cause severe developmental and metabolic complications. Our advanced next-generation sequencing technology provides unparalleled accuracy in detecting mutations within the PC gene, enabling precise diagnosis and informed medical decision-making.

What This Test Measures and Detects

This specialized genetic test utilizes next-generation sequencing (NGS) technology to comprehensively analyze the PC gene for pathogenic variants associated with pyruvate carboxylase deficiency. The test specifically identifies:

  • Point mutations, deletions, and insertions in the PC gene
  • Autosomal recessive inheritance patterns
  • Genetic markers for Leigh syndrome development
  • Metabolic pathway disruptions affecting energy production
  • Risk assessment for family members through genetic counseling

Who Should Consider This Test

This genetic test is particularly recommended for individuals displaying symptoms suggestive of pyruvate carboxylase deficiency or Leigh syndrome, including:

  • Infants and children with developmental regression or delay
  • Patients experiencing neurological symptoms such as seizures, ataxia, or hypotonia
  • Individuals with metabolic acidosis or lactic acidosis
  • Children showing failure to thrive or feeding difficulties
  • Patients with family history of Leigh syndrome or metabolic disorders
  • Individuals with unexplained neurological deterioration
  • Those with abnormal brain imaging showing characteristic lesions

Significant Benefits of Genetic Testing

Undergoing the PC Gene Leigh Syndrome NGS Genetic DNA Test provides numerous clinical advantages:

  • Accurate Diagnosis: Confirms or rules out pyruvate carboxylase deficiency with high precision
  • Early Intervention: Enables timely treatment initiation to potentially slow disease progression
  • Family Planning: Provides crucial information for genetic counseling and reproductive decisions
  • Personalized Treatment: Guides development of targeted therapeutic approaches
  • Prognostic Information: Helps predict disease course and potential complications
  • Research Contribution: Advances understanding of rare neurological disorders

Understanding Your Test Results

Our comprehensive genetic counseling services help you interpret your test results effectively:

  • Positive Result: Indicates the presence of pathogenic PC gene mutations, confirming pyruvate carboxylase deficiency diagnosis
  • Negative Result: Suggests absence of known pathogenic variants, though clinical correlation remains essential
  • Variant of Uncertain Significance: Identifies genetic changes requiring further investigation and family studies
  • Carrier Status: Determines if individuals carry one copy of the mutated gene without showing symptoms

All results are accompanied by detailed explanations and recommendations from our certified genetic counselors to ensure complete understanding and appropriate next steps.

Test Details and Pricing

Test Component Details
Test Name PC Gene Leigh Syndrome Due to Pyruvate Carboxylase Deficiency NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Specialty Neurologist
Department Genetics
Method NGS Technology
Disease Type Neurological Disorders

Pre-Test Instructions

To ensure optimal testing conditions and accurate results, please follow these pre-test requirements:

  • Provide complete clinical history of the patient undergoing testing
  • Participate in a genetic counseling session prior to testing
  • Prepare a detailed pedigree chart of family members affected with PC Gene Leigh syndrome
  • Discuss testing implications and potential outcomes with our genetic specialists
  • Ensure proper sample collection according to our laboratory guidelines

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take Action Today

Don’t wait to get the answers you need for proper diagnosis and treatment planning. Our team of genetic specialists and neurologists is ready to assist you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your PC Gene Leigh Syndrome NGS Genetic DNA Test and take the first step toward accurate diagnosis and personalized care management.

Early genetic testing can make a significant difference in managing pyruvate carboxylase deficiency and improving quality of life for affected individuals and their families.